Cell therapy in the heart

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 3, 2012, Pages 307-315

  Abdelli, Latifa S ^a   Merino, Hilda ^a   Rocher, Crystal M ^a   Singla, Dinender K ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adult and embryonic stem cells; Cardiac myocytes; Cardiomyopathy; Cell transplantation therapy; Clinical trials

Indexed keywords

AZACITIDINE; DIMETHYL SULFOXIDE; RETINOIC ACID;

ACUTE HEART INFARCTION; ADULT STEM CELL; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CELL THERAPY; CELL TRANSPLANTATION; CELL TYPE; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HUMAN; MEDICAL LITERATURE; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ADULT STEM CELLS; ANIMALS; CARDIOMYOPATHIES; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOBLASTS, SKELETAL; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 84858026090     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-130     Document Type: Review

References (72)

1. Ahuja, P., Sdek, P., and MacLellan, W.R. 2007. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87(2): 521-544. doi:10.1152/physrev.00032.2006.
2. Anversa, P., and Kajstura, J. 1998. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ. Res. 83(1):1-14.
3. Assmus, B., Schächinger, V., Teupe, C., Britten, M., Lehmann, R., Dobert, N., et al. 2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 106(24): 3009-3017. doi:10.1161/01.CIR.0000043246.74879.CD.
4. Bai, X., and Alt, E. 2010. Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem. Biophys. Res. Commun. 401(3): 321-326. doi:10.1016/j.bbrc.2010.09.012.
5. Bai, X., Yan, Y., Song, Y.H., Seidensticker, M., Rabinovich, B., Metzele, R., et al. 2010. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur. Heart J. 31(4): 489-501. doi:10.1093/eurheartj/ehp568.
6. Balsam, L.B., and Robbins, R.C. 2005. Haematopoietic stem cells and repair of the ischaemic heart. Clin. Sci. (Lond.), 109(6): 483-492. doi:10.1042/CS20050087.
7. Barile, L., Messina, E., Giacomello, A., and Marban, E. 2007. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 50(1): 31-48. doi:10.1016/j.pcad.2007.03.005.
8. Beltrami, A.P., Urbanek, K., Kajstura, J., Yan, S.M., Finato, N., Bussani, R., et al. 2001. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344(23): 1750-1757. doi:10.1056/NEJM200106073442303.
9. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6): 763-776. doi:10.1016/S0092-8674(03)00687-1.
10. Boyle, A.J., Schulman, S.P., Hare, J.M., and Oettgen, P. 2006. Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step. Circulation, 114(4): 339-352. doi:10.1161/CIRCULATIONAHA.105.590653.
11. Carvajal-Vergara, X., Sevilla, A., D'Souza, S.L., Ang, Y.S., Schaniel, C., Lee, D.F., et al. 2010. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature, 465 (7299): 808-812. doi:10.1038/nature09005.
12. Cleland, J.G., Torabi, A., and Khan, N.K. 2005. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart, 91(Suppl. 2): ii7-ii13, discussion ii31, ii43-ii48. doi:10.1136/hrt.2005.062026.
13. Deten, A., Volz, H.C., Clamors, S., Leiblein, S., Briest, W., Marx, G., and Zimmer, H. 2005. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc. Res. 65(1): 52-63. doi:10.1016/j.cardiores.2004.11.009.
14. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., et al. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321(5893): 1218-1221. doi:10.1126/science.1158799.
15. Dowell, J.D., Rubart, M., Pasumarthi, K.B., Soonpaa, M.H., and Field, L.J. 2003. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res. 58(2): 336-350. doi:10.1016/S0008-6363(03)00254-2.
16. Ebert, A.D., Yu, J., Rose, F.F., Jr, Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457 (7227): 277-280. doi:10.1038/nature07677.
17. Egelhoff, T.T., and Fisher, S.A. 2006. Cardiac myocyte cytokinesis: the contractile ring is the thing. J. Mol. Cell. Cardiol. 41(4): 592-594. doi:10.1016/j.yjmcc.2006.07.013.
18. Eisenberg, L.M., Burns, L., and Eisenberg, C.A. 2003. Hematopoietic cells from bone marrow have the potential to differentiate into cardiomyocytes in vitro. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 274(1): 870-882. doi:10.1002/ar.a.10106.
19. Fong, C.Y., Gauthaman, K., and Bongso, A. 2010. Teratomas from pluripotent stem cells: A clinical hurdle. J. Cell. Biochem. 111(4): 769-781. doi:10.1002/jcb.22775.
20. Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., et al. 2005. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11(4): 367-368. doi:10.1038/nm0405-367.
21. Haider, H.K., and Ashraf, M. 2005. Bone marrow stem cell transplantation for cardiac repair. Am. J. Physiol. Heart Circ. Physiol. 288(6): H2557-H2567. doi:10.1152/ajpheart.01215.2004.
22. Hirata, Y., Sata, M., Motomura, N., Takanashi, M., Suematsu, Y., Ono, M., and Takamoto, S. 2005. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 327(2): 609-614. doi:10.1016/j.bbrc.2004.12.044.
23. Huikuri, H.V., Kervinen, K., Niemela, M., Ylitalo, K., Saily, M., Koistinen, P., Savolainen, E.R., et al. 2008. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur. Heart J. 29: 2723-2732.
24. Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., et al. 2000. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6(2): 88-95.
25. Kajstura, J., Leri, A., Finato, N., Di Loreto, C., Beltrami, C.A., and Anversa, P. 1998. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. U.S.A. 95(15): 8801-8805. doi:10.1073/pnas.95.15.8801.
26. Kim, B.O., Tian, H., Prasongsukarn, K., Wu, J., Angoulvant, D., Wnendt, S., et al. 2005. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation, 112(9 Suppl.): I96-I104.
27. Kögler, G., Sensken, S., Airey, J.A., Trapp, T., Müschen, M., Feldhahn, N., et al. 2004. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200(2): 123-135. doi:10.1084/jem.20040440.
28. Kumar, D., Kamp, T.J., and LeWinter, M.M. 2005. Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration. Coron. Artery Dis. 16(2): 111-116. doi:10.1097/00019501-200503000-00006.
29. Leor, J., Patterson, M., Quinones, M.J., Kedes, L.H., and Kloner, R. A. 1996. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation, 94(9 Suppl.): II332-II336.
30. + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115: 3165-3172.
31. + cell therapy for refractory angina. Circ. Res. 109(4): 428-436. doi:10.1161/CIRCRESAHA.111.245993.
32. Menasché, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., et al. 2008. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation, 117(9): 1189-1200. doi:10.1161/CIRCULATIONAHA.107.734103.
33. Meyer, G.P., Wollert, K.C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., et al. 2006. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113 (10): 1287-1294. doi:10.1161/CIRCULATIONAHA.105.575118.
34. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al. 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1): 101-106. doi:10.1038/nbt1374.
35. Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L., Solomon, S. D., Deb, A., et al. 2006. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol. Ther. 14(6): 840-850. doi:10.1016/j.ymthe.2006.05.016.
36. Nussbaum, J., Minami, E., Laflamme, M.A., Virag, J.A., Ware, C.B., Masino, A., et al. 2007. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21(7): 1345-1357. doi:10.1096/fj.06-6769com.
37. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., and Yamanaka, S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903): 949-953. doi:10.1126/science.1164270.
38. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829): 701-705. doi:10.1038/35070587.
39. Pagani, F.D., DerSimonian, H., Zawadzka, A., Wetzel, K., Edge, A. S., Jacoby, D.B., et al. 2003. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41(5): 879-888. doi:10.1016/S0735-1097(03)00081-0.
40. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., et al. 2008. Disease-specific induced pluripotent stem cells. Cell, 134(5): 877-886. doi:10.1016/j.cell.2008.07.041.
41. Perin, E.C., Dohmann, H.F., Borojevic, R., Silva, S.A., Sousa, A.L., Mesquita, C.T., et al. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 107(18): 2294-2302. doi:10.1161/01.CIR.0000070596.30552.8B.
42. Reffelmann, T., and Kloner, R.A. 2003. Cellular cardiomyoplasty-cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc. Res. 58 (2): 358-368. doi:10.1016/S0008-6363(02)00739-3.
43. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J.E., et al. 2004. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109(10): 1292-1298. doi:10.1161/01.CIR.0000121425.42966.F1.
44. Rigol, M., Solanes, N., Farre, J., Roura, S., Roque, M., Berruezo, A., et al. 2010. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J. Card. Fail. 16(4): 357-366. doi:10.1016/j.cardfail.2009.12.006.
45. Sadat, S., Gehmert, S., Song, Y.H., Yen, Y., Bai, X., Gaiser, S., et al. 2007. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 363(3): 674-679. doi:10.1016/j.bbrc.2007.09.058.
46. Sakai, T., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Tomita, S., et al. 1999. Autologous heart cell transplantation improves cardiac function after myocardial injury. Ann. Thorac. Surg. 68(6): 2074-2080, discussion 2080-2081. doi:10.1016/S0003-4975(99)01148-0.
47. Schächinger, V., Assmus, B., Britten, M.B., Honold, J., Lehmann, R., Teupe, C., et al. 2004. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44(8): 1690-1699.
48. Schächinger, V., Tonn, T., Dimmeler, S., and Zeiher, A.M. 2006. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1): S23-S28. doi:10.1038/ncpcardio0441.
49. Schipper, B.M., Marra, K.G., Zhang, W., Donnenberg, A.D., and Rubin, J.P. 2008. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann. Plast. Surg. 60(5): 538-544. doi:10.1097/SAP.0b013e3181723bbe.
50. Schmidt, E.V. 1999. The role of c-myc in cellular growth control. Oncogene, 18(19): 2988-2996. doi:10.1038/sj.onc.1202751.
51. Scorsin, M., Marotte, F., Sabri, A., Le Dref, O., Demirag, M., Samuel, J.L., et al. 1996. Can grafted cardiomyocytes colonize peri-infarct myocardial areas? Circulation, 94(9 Suppl.): II337-II340.
52. Singla, D.K. 2009. Embryonic stem cells in cardiac repair and regeneration. Antioxid. Redox Signal. 11(8): 1857-1863. doi:10.1089/ars.2009.2491.
53. Singla, D.K., and McDonald, D.E. 2007. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 293(3): H1590-H1595. doi:10.1152/ajpheart.00431.2007.
54. Singla, D.K., and Sobel, B.E. 2005. Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration. Biochem. Biophys. Res. Commun. 335(3): 637-642. doi:10.1016/j.bbrc.2005.06.105.
55. Singla, D.K., Hacker, T.A., Ma, L., Douglas, P.S., Sullivan, R., Lyons, G.E., and Kamp, T.J. 2006. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J. Mol. Cell. Cardiol. 40(1): 195-200. doi:10.1016/j.yjmcc.2005.09.001.
56. Singla, D.K., Long, X., Glass, C., Singla, R.D., and Yan, B. 2011. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Mol. Pharm. 8(5): 1573-1581. doi:10.1021/mp2001704.
57. Strauer, B.E., Yousef, M., and Schannwell, C.M. 2010. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur. J. Heart Fail. 12: 721-729.
58. Takahashi, K., and Yamanaka, S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4): 663-676. doi:10.1016/j.cell.2006.07.024.
59. Taylor, D.A., Atkins, B.Z., Hungspreugs, P., Jones, T.R., Reedy, M. C., Hutcheson, K.A., et al. 1998. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4(8): 929-933. doi:10.1038/nm0898-929.
60. + cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur. Heart J. 30(11): 1313-1321. doi:10.1093/eurheartj/ehp073.
61. Thygesen, K., Alpert, J.S., and White, H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. 2008. Uniwersalna definicja zawału serca [Universal definition of the myocardial infarction]. Kardiol. Pol. 66(1): 47-62.
62. Tse, H.F., Thambar, S., Kwong, Y.L., Rowlings, P., Bellamy, G., McCrohon, J., Thomas, P., et al. 2007. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur. Heart J. 28: 2998-3005.
63. Valina, C., Pinkernell, K., Song, Y.H., Bai, X., Sadat, S., Campeau, R.J., et al. 2007. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 28(21): 2667-2677. doi:10.1093/eurheartj/ehm426.
64. van der Laan, A., Hirsch, A., Nijveldt, R., van der Vleuten, P.A., van der Giessen, W.J., Doevendans, P.A., et al. 2008. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth. Heart J. 16(12): 436-439. doi:10.1007/BF03086194.
65. Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. 2004. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429): 141-148. doi:10.1016/S0140-6736(04)16626-9.
66. Woo, K.S. 2009. Perusal of risk stratification of acute myocardial infarction for half a century. Eur. Heart J. 30(9): 1030-1032. doi:10.1093/eurheartj/ehp129.
67. Yamashita, J.K. 2010. ES and iPS cell research for cardiovascular regeneration. Exp. Cell Res. 316(16): 2555-2559. doi:10.1016/j.yexcr.2010.04.004.
68. Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., et al. 2009a. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19(4): 429-438. doi:10.1038/cr.2009.28.
69. Zhang, J., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J., Palecek, S.P., et al. 2009b. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104(4): e30-e41. doi:10.1161/CIRCRESAHA.108.192237.
70. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., et al. 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4(5): 381-384. doi:10.1016/j.stem.2009.04.005.
71. Zhu, X.Y., Zhang, X.Z., Xu, L., Zhong, X.Y., Ding, Q., and Chen, Y.X. 2009. Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochem. Biophys. Res. Commun. 379(4): 1084-1090. doi:10.1016/j.bbrc.2009.01.019.
72. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., et al. 2001. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2): 211-228. doi:10.1089/107632701300062859.